Merck schizophrenia drug approved for 2 new uses
Merck & Co. said Tuesday its schizophrenia drug Saphris has been approved for two additional uses by the Food and Drug Administration.

Low-Carb Labels May Confuse More Than Educate
People often misinterpret product claims of low-carbohydrate content on the front of packages, believing the foods are healthy and will help them manage their weight, a study shows.